Beverly Hills, California, United States Libertas Capital appeared to be the Corporate Investor, which was created in 2002. The main office of represented Corporate Investor is situated in the Beverly Hills. The company was established in North America in United States.
The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2017.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - France. Among the most popular portfolio startups of the fund, we may highlight Ledger. We can highlight the next thriving fund investment areas, such as Blockchain, Cryptocurrency.
The typical case for the fund is to invest in rounds with more than 10 participants. Despite the Libertas Capital, startups are often financed by XAnge, Thibaut Fauru00e8s Fustel de Coulanges, Pascal Gauthier. The meaningful sponsors for the fund in investment in the same round are XAnge, Wicklow Capital, The Whittemore Collection. In the next rounds fund is usually obtained by XAnge, Samsung Ventures, Korelya Capital.
| Fund Name | Location |
| Aju Pharma | - |
| Carefusion | California, San Diego, United States |
| Cognicase | Canada, Montréal, Quebec |
| EMV Capital | England, London, United Kingdom |
| Health Innovation Fund | California, Oakland, United States |
| Los Angeles Times Media Group | California, Los Angeles, United States |
| Media General | Sandston, United States, Virginia |
| Ozone Ventures | - |
| Suzhou Youcai Huiying Investment Center | China, Jiangsu, Suzhou |
| Vestinwolf Alternatives | England, London, United Kingdom |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ledger | $7M | 30 Mar 2017 | Paris, Ile-de-France, France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ledger | $7M | 30 Mar 2017 | Paris, Ile-de-France, France |
